Anthony Edwin Musso

US Patent:

20140011829, Jan 9, 2014

Filed:

Jul 6, 2012

Appl. No.:

13/542702

Inventors:

Robert Lewis Steele - Palm Beach Gardens FL, US
Anthony Fedele Musso - West Palm Beach FL, US

International Classification:

A61K 31/4375
A61P 31/14

US Classification:

514280

Abstract:

The present invention describes a method of treating individuals suffering from microbial infections, including a viral infection such as Dengue Fever, using an improved Artemisinin Combination Therapy (ACT), known as Tri-ACT. The improved ACT therapy includes administering a combination of three drugs. In one embodiment of the present invention, the method includes administering to an individual a first composition comprising a therapeutically effective amount of an artemether spray sublingually. The individual is then administered a second composition, a therapeutically effective amount of artesunate. A third composition, an effective amount of berberine, or its pharmaceutically acceptable derivatives or salts is then administered to the individual.

US Patent:

58000143, Sep 1, 1998

Filed:

Mar 10, 1997

Appl. No.:

8/814441

Inventors:

Anthony F. Musso - Jupiter FL

International Classification:

B60N 226

US Classification:

297243

Abstract:

A children's bicycle seat for positioning of a child behind the handlebars of a conventional bicycle. The child's bicycle seat includes a pair of handlebar clamps and a handlebar support post bracket for securing a main frame structure to the handlebar of the bicycle in a three point stance. The upper frame member is adjustable in a horizontal plane allowing for the secure positioning of a children from nine months to four years of age. Adjustable foot supports also accommodate the various sized children that are positioned within the seat. The seating structure is formed from a single piece of fabric having preformed apertures allowing securement to the frame when the frame is in a disassembled state. The seat is attached to foot supports to prevent the child's legs from impacting the rotating wheel.

US Patent:

20140256761, Sep 11, 2014

Filed:

Mar 7, 2014

Appl. No.:

14/201740

Inventors:

Robert Lewis Steele - Palm Beach Gardens FL, US
Anthony Fedele Musso - West Palm Beach FL, US
David D. Mundschenk - Hollywood FL, US
Russell Van de Casteele - Pompano Beach FL, US

International Classification:

A61K 31/47
A61K 31/357
A61K 31/4375

US Classification:

514280

Abstract:

The present invention describes a method of treating individuals suffering from microbial infections, including a parasitic disease such as malaria, by using an improved Artemisinin Combination Therapy (ACT), known as ActRx Tri-ACT Plus. The improved ACT therapy includes administering a combination of four drugs. In one embodiment of the present invention, the method includes administering to an individual a first composition comprising a therapeutically effective amount of an artemether spray sublingually. The individual is then administered a second composition, a therapeutically effective amount of artesunate. A third composition, an effective amount of berberine, or its pharmaceutically acceptable derivatives or salts is administered to the individual. A fourth composition, an effective amount of primaquine, or its pharmaceutically acceptable derivatives or salts is administered to the individual.

US Patent:

20140256762, Sep 11, 2014

Filed:

Mar 7, 2014

Appl. No.:

14/201749

Inventors:

Robert Lewis Steele - Palm Beach Gardens FL, US
Anthony Fedele Musso - West Palm Beach FL, US
David D. Mundschenk - Hollywood FL, US
Russell Van de Casteele - Pompano Beach FL, US

International Classification:

A61K 31/4375
A61K 31/357

US Classification:

514280

Abstract:

The present invention describes a method of treating individuals suffering from microbial infections, including a viral infection such as Dengue Fever, using an improved Artemisinin Combination Therapy (ACT), known as Tri-ACT. The improved ACT therapy includes administering a combination of three drugs. In one embodiment of the present invention, the method includes administering to an individual a first composition comprising a therapeutically effective amount of an artemether spray sublingually. The individual is then administered a second composition, a therapeutically effective amount of artesunate. A third composition, an effective amount of berberine, or its pharmaceutically acceptable derivatives or salts is then administered to the individual.